0001567619-23-000919.txt : 20230113 0001567619-23-000919.hdr.sgml : 20230113 20230113164909 ACCESSION NUMBER: 0001567619-23-000919 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230112 FILED AS OF DATE: 20230113 DATE AS OF CHANGE: 20230113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Devin Whittemore CENTRAL INDEX KEY: 0001747818 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41008 FILM NUMBER: 23529291 MAIL ADDRESS: STREET 1: C/O MINERVA NEUROSCIENCES, INC. STREET 2: 1601 TRAPELO ROAD, SUITE 286 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IO Biotech, Inc. CENTRAL INDEX KEY: 0001865494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870909276 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 BUSINESS PHONE: 4570702980 MAIL ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 4 1 doc1.xml FORM 4 X0306 4 2023-01-12 0 0001865494 IO Biotech, Inc. IOBT 0001747818 Smith Devin Whittemore C/O IO BIOTECH, INC. OLE MAALOES VEH 3 COPENHAGEN G7 2200 DENMARK 0 1 0 0 General Counsel Stock Option (Right to Buy) 2.60 2023-01-12 4 A 0 150000 0 A 2033-01-12 Common Stock 150000 150000 D One-fourth of these options vest on January 12, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the Issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control. /s/ Brian Burkavage, Attorney-in-Fact for Devin W. Smith 2023-01-13